2024-514520-16-00Not yet recruitingPhase 1
A Randomized, Double-Blind, Placebo Controlled, Multi - Center, Phase 1b Study to Evaluate the Safety and Tolerability of LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis
Source: EU CTIS (euclinicaltrials.eu) · Last updated 10 Aug 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (estimated)
- First submitted
- 23 Jul 2024
- Start date
- 27 Jan 2025
- Lead sponsor
- Medytox Inc.
- Diseases
- Ulcerative colitis
- EU CT number
- 2024-514520-16-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 8
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centrum Medyczne Medyk Sp. z o.o. Coordinator of this site? Confirm its status | Rzeszow | Poland | Not yet recruiting |
| Provita Poliklinika sp. z o.o Coordinator of this site? Confirm its status | Warsaw | Poland | Not yet recruiting |
| Centrum Badań Klinicznych Piotr Napora Lekarze Sp. p. Coordinator of this site? Confirm its status | Wroclaw | Poland | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.